𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of Increased Cerebral myo-Inositol in the Dementia of Down Syndrome

✍ Scribed by Truda Shonk; Brian D. Ross


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
364 KB
Volume
33
Category
Article
ISSN
0740-3194

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The purpose of this study was to determine cerebral myo‐inositol (ml) in adults with Down syndrome (DS), and to trace the chronobiology of DS to Alzheimer disease (AD). AD has characteristic neuropathology of neurofibrillary plaques and tangles; indirect evidence links this to earlier deposition of β‐amyloid. Elevated ml, which distinguishes AD from other common dementias, is also elevated in 23 young patients who have DS without dementia. In one patient who has DS with dementia, ml is elevated and N‐acetylaspartate (NAA) decreased. The similarity to AD is striking and may suggest a progressive neurochemical disorder in which elevation of ml precede loss of NAA in both AD and DS.


πŸ“œ SIMILAR VOLUMES


Visual evoked potential in the diagnosis
✍ Dr. V. P. Prasher; V. H. R. Krishnan; A. Blake; D. J. Clarke; J. A. Corbett πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 447 KB πŸ‘ 1 views

## Abstract The diagnosis of dementia in people with Down syndrome (DS) remains controversial. In this study DS patients who had a diagnosis of clinical dementia according to modified DSM‐III‐R criteria were assessed using the flash (P2) and pattern‐reversal (P100) visual evoked potential (VEP). Ab

Presenilin 1 and ?-1-antichymotrypsin po
✍ Tyrrell, Janette; Cosgrave, Mary; McPherson, Janet; Hawi, Ziarih; Trulock, Vivie πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 24 KB πŸ‘ 2 views

As people with Down syndrome (DS) age, they are at greater risk for Alzheimer disease (AD) than the general population. It has been suggested that polymorphisms at the genes for presenilin-1 (PS-1) and ␣-1antichymotrypsin (ACT) confer an increased risk for AD in the general population, and therefore

Amniotic Fluid and Maternal Serum Levels
✍ K. Spencer; F. Muller; D. A. Aitken πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 45 KB πŸ‘ 2 views

In a study of amniotic fluid from 91 Down syndrome cases and 240 controls, we have shown that the median value of CA125 in pregnancies affected by Down syndrome on the whole reflects those observed in the maternal serum from 106 affected cases and 238 controls. The median MOM for CA125 in amniotic f

Significant effect of APOE epsilon 4 gen
✍ V. P. Prasher; S. G. Sajith; S. D. Rees; A. Patel; S. Tewari; N. Schupf; W. B. Z πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 1 views

## Abstract ## Objective Virtually all adults with Down syndrome (DS) have neuropathological manifestations of Dementia in Alzheimer's disease (DAD) but not all develop clinical psychopathology. The effect of allelic variants of Apolipoprotein (APOE) gene in development and progression of DAD and